Sx. Chen et al., Characterization of the human EPLIN (Epithelial Protein Lost in Neoplasm) gene reveals distinct promoters for the two EPLIN isoforms, GENE, 248(1-2), 2000, pp. 69-76
EPLIN is a novel LIM domain protein that co-localizes to the actin stress f
ibers and focal adhesion plaques. We previously have demonstrated that two
isoforms, the 600 aa EPLIN-alpha and the 759 aa EPLIN-beta, are generated f
rom a single gene. In the majority of human breast and prostate cancer cell
lines, the expression of EPLIN-a is significantly reduced, while the expre
ssion of EPLIN-beta is either up-regulated or unchanged. To understand the
basis of this differential regulation, we have determined the organization
of the human EPLIN gene. The human EPLIN gene spans > 100 kb and consists o
f 11 exons. The EPLIN-beta mRNA requires all 11 exons, while the EPLIN-a mR
NA requires Exons 4-11. The transcriptional start sites of EPLIN-a were map
ped within the third intron by 5' RACE and Si nuclease protection. Similarl
y, the 5' ends of EPLIN-beta were mapped upstream of Exon 1. The DNA sequen
ces flanking the EPLIN-alpha or EPLIN-beta transcriptional start sites were
capable of stimulating the expression of promoter reporter constructs. Int
erestingly, the endogenous transcription of EPLIN-a, but not EPLIN-beta, co
uld be stimulated by serum, indicating that the expression of two EPLIN iso
forms can be independently regulated. A consensus serum response element wa
s present within 100 bp upstream of the transcriptional start sites of EPLI
N-alpha. The activity of 0.7 kb EPLIN-alpha promoter reporter construct cou
ld be enhanced by activated RhoA, indicating that this serum response eleme
nt is functional. (C) 2000 Elsevier Science B.V. All rights reserved.